Bridging Chemotherapy Gaps For Adult Oncology Patients

For adults diagnosed with cancer in Armenia, access to surgery is often guaranteed. Chemotherapy is not.

While oncology surgeries are covered by the state, chemotherapy support is capped at $800, an amount that rarely reflects real treatment costs. For many patients, the state-funded quota runs out halfway through the year, leaving them without access to essential, life-saving medications at the most critical stage of treatment.

When chemotherapy is interrupted, the consequences are severe: disease progression, treatment failure, and loss of precious time.

In 2025 alone, 57 adult oncology patients relied on individual, targeted fundraising just to continue their chemotherapy. These are not optional medicines — they are standard components of oncology care.

Your support will deliver a direct, life-saving impact. Below are examples of commonly required medications and their approximate costs:
- Cytosar (1000 ml) – $880
- Meropenem (1 g) – $55
- Octagam – $800
- Cytarabine (1000 ml) – $50
- Perjeta (420 ml) – $1300
- Filgrastim (300 mcg) – $400
- Docetaxel (120 ml) – $90
- Carboplatin (900 ml) – $350
- Darzalex (120 ml) – $310
- Carfilzomib – $265
- Bendamustine (300 ml) – $370
- Cyclophosphamide (300 ml) – $630
- Atezolizumab (1200 ml) – $3200
- Bevacizumab (600 ml) – $1200
- MabThera (600 ml) – $1600
(Final medication list and quantities are confirmed case-by-case, based on physician prescriptions.)

Through this project, funds are used immediately and directly to cover chemotherapy-related gaps, ensuring that treatment plans prescribed by oncologists can actually be completed. Every contribution helps prevent avoidable delays and gives patients a fair chance to fight their disease.

Cancer treatment should not stop because funding runs out. Help patients continue treatment when it matters most!